Icad Inc Stock Alpha and Beta Analysis

ICAD Stock  USD 1.70  0.01  0.59%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as icad inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Icad over a specified time horizon. Remember, high Icad's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Icad's market risk premium analysis include:
Sharpe Ratio
Expected Return
Please note that although Icad alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Icad did 0.03  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of icad inc stock's relative risk over its benchmark. icad inc has a beta of 1.98  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Icad will likely underperform. The current year's Tangible Book Value Per Share is expected to grow to 1.65, whereas Book Value Per Share is forecasted to decline to 1.24.

Enterprise Value

44.9 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Icad Backtesting, Icad Valuation, Icad Correlation, Icad Hype Analysis, Icad Volatility, Icad History and analyze Icad Performance.

Icad Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Icad market risk premium is the additional return an investor will receive from holding Icad long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Icad. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Icad's performance over market.
α0.03   β1.98

Icad expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Icad's Buy-and-hold return. Our buy-and-hold chart shows how Icad performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Icad Market Price Analysis

Market price analysis indicators help investors to evaluate how Icad stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Icad shares will generate the highest return on investment. By understating and applying Icad stock market price indicators, traders can identify Icad position entry and exit signals to maximize returns.

Icad Return and Market Media

The median price of Icad for the period between Tue, Jan 16, 2024 and Mon, Apr 15, 2024 is 1.57 with a coefficient of variation of 11.55. The daily time series for the period is distributed with a sample standard deviation of 0.18, arithmetic mean of 1.58, and mean deviation of 0.14. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
Insider Trading
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD,
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024 Showcases Additional ...
iCAD, Inc. Stock Rockets 26 percent As Investors Are Less Pessimistic Than Expected
Acquisition by Susan Wood of 3879 shares of Icad subject to Rule 16b-3
Is iCAD Inc Stock at the Top of the Medical Devices Industry - InvestorsObserver
iCAD, Inc. Q4 2023 Earnings Call Transcript
iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
iCAD Share Price Crosses Above 200 Day Moving Average of 1.63 - Defense World
Acquisition by Sassine Andy of 25259 shares of Icad at 1.52 subject to Rule 16b-3
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries
iCADs ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

About Icad Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Icad or other stocks. Alpha measures the amount that position in icad inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2023 2024 (projected)
Dividend Yield3.31E-43.8E-43.61E-4
Price To Sales Ratio5.32.625.08

Icad Upcoming Company Events

As portrayed in its financial statements, the presentation of Icad's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Icad's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Icad's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Icad. Please utilize our Beneish M Score to check the likelihood of Icad's management manipulating its earnings.
26th of March 2024
Upcoming Quarterly Report
31st of December 2023
Next Fiscal Quarter End

Build Portfolio with Icad

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether icad inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:
Check out Icad Backtesting, Icad Valuation, Icad Correlation, Icad Hype Analysis, Icad Volatility, Icad History and analyze Icad Performance.
Note that the icad inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Icad technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Icad technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Icad trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...